We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+36.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$3.01B
AUM Growth
+$583M
Cap. Flow
-$32.3M
Cap. Flow %
-1.07%
Top 10 Hldgs %
19.61%
Holding
374
New
40
Increased
94
Reduced
116
Closed
88

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$26.9M
2
EBC icon
Eastern Bankshares
EBC
+$24.9M
3
MAX icon
MediaAlpha
MAX
+$21.2M
4
HLI icon
Houlihan Lokey
HLI
+$19.7M
5
ALGM icon
Allegro MicroSystems
ALGM
+$18.9M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$43.8M
2
BLD
TopBuild
BLD
+$38.3M
3
TWST icon
Twist Bioscience
TWST
+$28.8M
4
QTS
QTS REALTY TRUST, INC.
QTS
+$25M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 23.28%
2 Technology 20.52%
3 Consumer Discretionary 15.17%
4 Industrials 13.7%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDRX icon
276
GoodRx Holdings
GDRX
$1.03B
$20K ﹤0.01%
484
-1,766
-78% -$81.1K
JSDA
277
DELISTED
JONES SODA CO
JSDA
$17K ﹤0.01%
74,124
– –
TWTR
278
DELISTED
Twitter, Inc.
TWTR
$5K ﹤0.01%
100
– –
EMAN
279
DELISTED
eMagin Corporation
EMAN
$2K ﹤0.01%
1,000
– –
TIGO icon
280
Millicom
TIGO
$16B
$1K ﹤0.01%
22
– –
ADEA icon
281
Adeia
ADEA
$2.88B
$0 ﹤0.01%
15
-3,916
-100% -$17K
AGS
282
DELISTED
PlayAGS
AGS
– –
-815,736
Closed -$2.89M
AKAM icon
283
Akamai
AKAM
$16.4B
– –
-2,601
Closed -$288K
AL
284
DELISTED
Air Lease Corp
AL
– –
-398
Closed -$12K
ALE
285
DELISTED
Allete
ALE
– –
-220
Closed -$11K
APOG icon
286
Apogee Enterprises
APOG
$855M
– –
-397
Closed -$8K
ASMB icon
287
Assembly Biosciences
ASMB
$513M
– –
-26,475
Closed -$5.22M
BDC icon
288
Belden
BDC
$4.12B
– –
-373
Closed -$12K
BDTX icon
289
Black Diamond Therapeutics
BDTX
$99.1M
– –
-2,643
Closed -$80K
BLUE
290
DELISTED
bluebird bio
BLUE
– –
-4
Closed -$3K
BNTX icon
291
BioNTech
BNTX
$23B
– –
-3,986
Closed -$276K
C icon
292
Citigroup
C
$223B
$0 ﹤0.01%
6
– –
CFFI icon
293
C&F Financial
CFFI
$258M
– –
-352
Closed -$10K
CLF icon
294
Cleveland-Cliffs
CLF
$6.99B
– –
-2,189
Closed -$14K
CRK icon
295
Comstock Resources
CRK
$3.82B
– –
-986
Closed -$4K
CUBI icon
296
Customers Bancorp
CUBI
$2.66B
– –
-677
Closed -$8K
EQIX icon
297
Equinix
EQIX
$103B
– –
-1,128
Closed -$857K
EQT icon
298
EQT Corp
EQT
$32.5B
– –
-15,594
Closed -$202K
ETSY icon
299
Etsy
ETSY
$7.96B
– –
-5,157
Closed -$627K
FFIC
300
DELISTED
Flushing Financial
FFIC
– –
-1,222
Closed -$13K
10 11
12
13 14

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Emerald Advisers held 374 positions worth $3.01B, up 24% from $2.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2020 filing shows 40 new, 94 increased, 116 reduced and 88 closed positions. Its largest new stake was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $43.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2020 buy was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M.
  • Emerald Advisers added most to Arena Pharmaceuticals Inc in Q4 2020, an estimated $18.6M increase.
  • Emerald Advisers's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $43.8M.
  • Emerald Advisers fully exited Pluralsight, Inc. Class A Common Stock in Q4 2020, selling an estimated $24.1M.
  • Emerald Advisers's ten largest holdings make up 20% of its $3.01B portfolio in Q4 2020.
  • Emerald Advisers opened 40 new positions and closed 88 in Q4 2020.
  • Emerald Advisers's portfolio value rose 24% quarter-over-quarter to $3.01B.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.